Alkahest Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 71
  • Latest Deal Type
  • M&A
  • (Announced)
  • Latest Deal Amount
  • $146M
Latest Deal Amount

Alkahest General Information


Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process. The company's therapies are used to augment the factors in the blood plasma in order to reverse detrimental effects of aging in both normal aging and disease models in animals, enabling doctors to improve vitality and find treatment for diseases of aging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 125 Shoreway Road
  • Suite D
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alkahest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 07-Sep-2020 $146M 000.00 00000 Announced Clinical Trials - Phase 2
4. Grant 12-Feb-2018 000.00 Completed Clinical Trials - Phase 2
3. Corporate 23-Nov-2015 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 03-Mar-2015 $3.5M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 10-Jul-2014 $3.5M $3.5M Completed Clinical Trials - Phase 2
To view Alkahest’s complete valuation and funding history, request access »

Alkahest Executive Team (8)

Name Title Board Seat Contact Info
Elizabeth Jeffords Chief Commercial & Strategy Officer
Steven Braithwaite Ph.D Chief Scientific Officer
Debbie Wallace Controller & Vice President of Finance
Robert Klein Chief Business Officer
Tamara Kent Vice President, Human Resources and Operations
You’re viewing 5 of 8 executive team members. Get the full list »

Alkahest Board Members (5)

Name Representing Role Since
David Bell Grifols Board Member 000 0000
Joseph McCracken Self Board Member 000 0000
Karoly Nikolich Ph.D Self Co-Founder, Chief Executive Officer & Chairman 000 0000
Thomas Glanzmann Alkahest Board Member 000 0000
Tony Wyss-Coray Ph.D Alkahest Co-Founder, Board Member & Chairman of Scientific Advisory Board 000 0000
To view Alkahest’s complete board members history, request access »

Alkahest Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial